Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00860509
Other study ID # PBRC26030
Secondary ID
Status Completed
Phase N/A
First received March 11, 2009
Last updated May 2, 2012
Start date November 2006
Est. completion date March 2007

Study information

Verified date May 2012
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The objective of this study is to compare cholesterol absorption and metabolism after feeding diets naturally low or high in phytosterols. All meals will be prepared in a metabolic kitchen and analyzed for phytosterols. In a randomized crossover design a group of up to 25 healthy subjects will consume diets containing either 100 mg/day or 600 mg/day phytosterols for 4 weeks. At the end of each dietary period percent cholesterol absorption, fecal cholesterol excretion and LDL cholesterol level will be measured. The hypothesis is that LDL cholesterol and cholesterol excretion will be improved on the high phytosterol diet even though macronutrient composition, mineral intake and fiber consumption are similar.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2007
Est. primary completion date March 2007
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria:

- Male or female of any race or ethnicity between 18 to 80 years of age, inclusive;

- Body mass index between 20-35 kg/m2;

- LDL-cholesterol between 100-189 mg/dL based on the average of duplicate screening measures. If the two LDL-C levels differ by more than 30 mg/dL, a third test will be scheduled with all three results averaged;

- Free of chronic disease;

- Willing to eat only the foods that are provided by the Center during the diet periods;

- Willing to consume no more than 1 alcoholic drink per day.

- Willing to abstain from the consumption of alcohol for 48-hours prior to blood draw days;

- Willing to drink no more than 5 cups of caffeine-containing beverages a day.

Exclusion Criteria:

- Age < 18 or > 80 years;

- Based on duplicate screening laboratory values: 1) LDL-C > or = 190 mg/dL; 2) TG > or = 250 mg/dL; 3) blood pressure > or = 160 mm Hg systolic or 95 mm Hg diastolic;

- Documented presence of atherosclerotic disease;

- Diabetes mellitus;

- Renal, hepatic, endocrine, gastrointestinal, hematological or other systemic disease;

- Body mass index > 35;

- For women, pregnancy, breast feeding or postpartum < 6 months;

- For women, peri-menopausal;

- History of drug or alcohol abuse;

- History of depression or mental illness requiring treatment or medication within the last 6 months;

- Multiple food allergies or significant food preferences or restrictions that would interfere with diet adherence;

- Chronic use of over-the-counter medication which would interfere with study endpoints including laxatives and antacids;

- Lifestyle or schedule incompatible with the study protocol;

- Planned continued use of dietary supplements through the study trial;

- Taking any lipid-lowering, or other medications known to affect blood cholesterol

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Basic Science


Intervention

Other:
Low Phytosterol and High Phytosterol Diets
Diets with 600 or 100 mg of daily phytosterols for 4 weeks were given to each subject, in random order

Locations

Country Name City State
United States Pennington Biomedical Research Center-Louisana State University System Baton Rouge Louisiana

Sponsors (2)

Lead Sponsor Collaborator
Washington University School of Medicine Pennington Biomedical Research Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

Lin X, Racette SB, Lefevre M, Spearie CA, Most M, Ma L, Ostlund RE Jr. The effects of phytosterols present in natural food matrices on cholesterol metabolism and LDL-cholesterol: a controlled feeding trial. Eur J Clin Nutr. 2010 Dec;64(12):1481-7. doi: 10 — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Fecal cholesterol excretion At the end of week 4 on each diet No
Secondary Intestinal cholesterol absorption At the end of week 4 on each diet No
See also
  Status Clinical Trial Phase
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Recruiting NCT03947866 - Ezetimibe-Rosuvastatin Evaluation Study
Completed NCT01709513 - Study of Alirocumab (REGN727/SAR236553) in Patients With Primary Hypercholesterolemia and Moderate, High, or Very High Cardiovascular (CV) Risk, Who Are Intolerant to Statins (ODYSSEY ALTERNATIVE) Phase 3
Completed NCT01212900 - Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression Phase 4
Completed NCT00001154 - Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
Completed NCT02550288 - A Clinical Trial to Assess the Efficacy and Safety of MK-0653C in Japanese Participants With Hypercholesterolemia (MK-0653C-383) Phase 3
Completed NCT03929198 - Translation of Pritikin Program to the Community N/A
Completed NCT04485793 - Effect of a Dietary Supplement on Lipid Pattern and Liver Parameters in Hypercholesterolemia N/A
Completed NCT02341924 - Validating the "Foods for Health" Portfolio of Functional Food Products N/A
Active, not recruiting NCT02223793 - Vascular Lifestyle-Intervention and Screening in Pharmacy N/A
Completed NCT01934608 - The Effect of Synching Prescription Refills on Adherence N/A
Completed NCT01941836 - Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic Patients Phase 2
Recruiting NCT01705873 - Analysis on the Risk of Cardiovascular Events in HIV- Infected Subjects Treated With LPV/r Based HAART Regimen vs. an EFV Based Regimen N/A
Completed NCT01678521 - Effect of LDL-apheresis on PTX3 Plasma Levels in Hypercholesterolemic Patients N/A
Completed NCT01670734 - Pharmacokinetic and Tolerability of Alirocumab SAR236553 (REGN727) in Patients With Hepatic Impairment and in Healthy Subjects Phase 1
Completed NCT01370590 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/20 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 20 mg Tablets in Participants With High Cholesterol (MK-0653C-185 AM1) Phase 3
Completed NCT01370603 - A Study to Evaluate the Effectiveness of Ezetimibe/Atorvastatin 10 mg/40 mg Combination Tablet Compared to Marketed Ezetimibe 10 mg and Atorvastatin 40 mg Tablets in Participants With High Cholesterol (MK-0653C-190 AM1) Phase 3
Completed NCT01768403 - Centralised Pan-Algerian Survey on the Undertreatment of Hypercholesterolemia N/A
Completed NCT01575171 - Using Nudges to Implement Comparative Effectiveness N/A
Completed NCT01446679 - Special Drug Use-Results Survey of Lipitor Tablets N/A